{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T22:13:34Z","timestamp":1795126414205,"version":"4.10.3"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review aims to summarize recent developments in the epidemiology of rheumatoid arthritis (RA) focusing on disease burden, risk factors, and disease outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Globally, the prevalence of RA is increasing, affecting an estimated 17.6 million people worldwide. Emerging data implicate other environmental and occupational inhaled exposures apart from cigarette smoking as RA risk factors. Risk models integrating clinical, serological, and imaging data are useful in predicting the pre-RA to RA transition. Extra-articular manifestations and multimorbidity are key complications of RA that drive excess mortality and avoidable hospitalizations, though overall mortality trends in RA are improving. RA-associated interstitial lung disease is recognized to affect the lungs of early RA patients, and risk models based on clinical and advanced biomarker phenotyping have shown potential for risk stratification. Large cohort studies have identified heart failure and valvular heart disease as cardiovascular complications in RA, in addition to atherosclerosis. Observational studies continue to evaluate the safety of TNF inhibitors in the setting of cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>RA prevalence is rising globally, while mortality rates are declining. Continued investigation aimed at elucidating RA risk factors, the transition from pre-RA to RA, extra-articular involvement, and multimorbidity remains critical to optimize patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000001142","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:00:14Z","timestamp":1769666414000},"page":"69-75","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Epidemiology and outcomes of rheumatoid arthritis"],"prefix":"10.1097","volume":"38","author":[{"given":"Lauren E.","family":"Klingemann","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted R.","family":"Mikuls","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center"},{"name":"Veterans Affairs Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryant R.","family":"England","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center"},{"name":"Veterans Affairs Nebraska-Western Iowa Healthcare System, Omaha, Nebraska, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"R1-20260129","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"key":"R2-20260129","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pop.2018.02.010","article-title":"Early diagnosis and treatment of rheumatoid arthritis","volume":"45","author":"Littlejohn","year":"2018","journal-title":"Prim Care Clin Off Pract"},{"key":"R3-20260129","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and management of rheumatoid arthritis: a review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA"},{"key":"R4-20260129","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-20260129","first-page":"455","article-title":"Rheumatoid arthritis: common questions about diagnosis and management","volume":"97","author":"Wasserman","year":"2018","journal-title":"Am Fam Physician"},{"key":"R6-20260129","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"R7-20260129","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/ar4498","article-title":"Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis","volume":"16","author":"Di Giuseppe","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R8-20260129","doi-asserted-by":"crossref","first-page":"e0329434","DOI":"10.1371\/journal.pone.0329434","article-title":"Global trends in smoking-attributable rheumatoid arthritis burden: insights from GBD 2021","volume":"20","author":"Lin","year":"2025","journal-title":"PloS One"},{"key":"R9-20260129","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/rheumatology\/kel149","article-title":"Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"45","author":"Hyrich","year":"2006","journal-title":"Rheumatol Oxf Engl"},{"key":"R10-20260129","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/acr.25500","article-title":"Physician views and attitudes regarding tobacco-cessation strategies for patients with rheumatoid arthritis","volume":"77","author":"Lopez-Olivo","year":"2025","journal-title":"Arthritis Care Res"},{"key":"R11-20260129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/tobaccocontrol-2021-056535","article-title":"Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action","volume":"31","author":"Dai","year":"2022","journal-title":"Tob Control"},{"key":"R12-20260129","article-title":"Shared lung and joint T cell repertoire in early rheumatoid arthritis driven by cigarette smoking","author":"Venken","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"R13-20260129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13075-025-03543-6","article-title":"Smoking as a risk factor for rheumatoid arthritis: predominant association with IgA autoantibodies - comprehensive analysis of antimodified protein antibodies with smoking and genetic risk factors in rheumatoid arthritis","volume":"27","author":"van Wesemael","year":"2025","journal-title":"Arthritis Res Ther"},{"key":"R14-20260129","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/art.43113","article-title":"Associations of fire smoke and other pollutants with incident rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease","volume":"77","author":"Kronzer","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R15-20260129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acr.25403","article-title":"Fine particulate matter components and risk of rheumatoid arthritis: a large general Canadian Open Cohort Study","volume":"77","author":"Zhao","year":"2025","journal-title":"Arthritis Care Res"},{"key":"R16-20260129","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard-2022-223134","article-title":"Occupational inhalable agents constitute major risk factors for rheumatoid arthritis, particularly in the context of genetic predisposition and smoking","volume":"82","author":"Tang","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"R17-20260129","doi-asserted-by":"crossref","first-page":"152825","DOI":"10.1016\/j.semarthrit.2025.152825","article-title":"Healthy dietary pattern and risk of rheumatoid arthritis: a systematic review and meta-analysis","volume":"74","author":"Joerns","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"R18-20260129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ard.2025.01.042","article-title":"Predictors of arthritis development in individuals at risk of rheumatoid arthritis: a 5-year follow-up study from a large cohort","volume":"84","author":"Frazzei","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"R19-20260129","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.ard.2025.01.021","article-title":"EULAR\/ACR risk stratification criteria for development of rheumatoid arthritis in the risk stage of arthralgia","volume":"84","author":"van Steenbergen","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"R20-20260129","doi-asserted-by":"crossref","first-page":"SI242","DOI":"10.1093\/rheumatology\/kead246","article-title":"The Multimorbidity Web in rheumatoid arthritis","volume":"62","author":"England","year":"2023","journal-title":"Rheumatol Oxf Engl"},{"key":"R21-20260129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/acr.25184","article-title":"Multimorbidity patterns and rheumatoid arthritis disease outcomes: findings from a multicenter, prospective cohort","volume":"77","author":"Dutt","year":"2025","journal-title":"Arthritis Care Res"},{"key":"R22-20260129","doi-asserted-by":"crossref","first-page":"e005577","DOI":"10.1136\/rmdopen-2025-005577","article-title":"Multimorbidity burden predicts lower likelihood of remission and higher likelihood of disease flare in patients with rheumatoid arthritis","volume":"11","author":"Montes","year":"2025","journal-title":"RMD Open"},{"key":"R23-20260129","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/acr.25541","article-title":"Avoidable hospitalizations in persons with rheumatoid arthritis: a population-based study using administrative data","volume":"77","author":"Contreras","year":"2025","journal-title":"Arthritis Care Res"},{"key":"R24-20260129","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1093\/rheumatology\/keae670","article-title":"Comorbidity in incident rheumatoid arthritis: a nationwide case-control study with bidirectional follow-up","volume":"64","author":"Batko","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"R25-20260129","doi-asserted-by":"crossref","first-page":"E851","DOI":"10.1016\/S2665-9913(25)00158-4","article-title":"Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA","volume":"7","author":"McDermott","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"R26-20260129","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.43149","article-title":"Peripheral biomarker signatures in rheumatoid arthritis-associated interstitial lung disease","volume":"77","author":"Wheeler","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R27-20260129","first-page":"keae572","article-title":"Unique transcriptomic profile of peripheral blood monocytes in rheumatoid arthritis-associated interstitial lung disease","author":"Poole","year":"2024","journal-title":"Rheumatol Oxf Engl"},{"key":"R28-20260129","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1093\/rheumatology\/keaf200","article-title":"Real-world care patterns and specialist encounters of patients with systemic autoimmune rheumatic disease-related interstitial lung disease in the United States: a retrospective administrative claims database analysis","volume":"64","author":"Yang","year":"2025","journal-title":"Rheumatol Oxf Engl"},{"key":"R29-20260129","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/acr.25481","article-title":"Risk of incident heart failure and heart failure subtypes in patients with rheumatoid arthritis","volume":"77","author":"Kawano","year":"2025","journal-title":"Arthritis Care Res"},{"key":"R30-20260129","doi-asserted-by":"crossref","first-page":"152816","DOI":"10.1016\/j.semarthrit.2025.152816","article-title":"Risk and temporal trends of heart failure subtypes in rheumatoid arthritis","volume":"74","author":"Johnson","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"R31-20260129","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1001\/jamainternmed.2023.3087","article-title":"Aortic stenosis risk in rheumatoid arthritis","volume":"183","author":"Johnson","year":"2023","journal-title":"JAMA Intern Med"},{"key":"R32-20260129","doi-asserted-by":"crossref","first-page":"e042025","DOI":"10.1161\/JAHA.125.042025","article-title":"Association between rheumatoid arthritis and the risk of incident degenerative valvular heart disease: evidence from a prospective cohort study","volume":"14","author":"Wang","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"R33-20260129","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13075-015-0728-9","article-title":"Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis","volume":"17","author":"Simon","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"R34-20260129","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","article-title":"A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis","volume":"10","author":"Smitten","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"R35-20260129","doi-asserted-by":"crossref","first-page":"988","DOI":"10.3899\/jrheum.2025-0190","article-title":"Cumulative incidence of cancer screening for breast, cervical, prostate, and colorectal cancer in patients with rheumatoid arthritis","volume":"52","author":"Brooks","year":"2025","journal-title":"J Rheumatol"},{"key":"R36-20260129","article-title":"Detection of lung abnormalities in smokers with rheumatoid arthritis screened for lung cancer with low-dose chest computed tomography imaging in routine clinical care: results from a large multihospital system","author":"McDermott","year":"2025","journal-title":"Arthritis Care Res"},{"key":"R37-20260129","doi-asserted-by":"crossref","first-page":"291","DOI":"10.7326\/M17-2812","article-title":"Tumor necrosis factor inhibitors and cancer recurrence in Swedish patients with rheumatoid arthritis: a nationwide population-based cohort study","volume":"169","author":"Raaschou","year":"2018","journal-title":"Ann Intern Med"},{"key":"R38-20260129","doi-asserted-by":"crossref","first-page":"e005247","DOI":"10.1136\/rmdopen-2024-005247","article-title":"Cancer recurrence risk with bDMARD treatment in patients with rheumatoid arthritis and a history of cancer: a nationwide Danish register-based cohort study","volume":"11","author":"Westermann","year":"2025","journal-title":"RMD Open"},{"key":"R39-20260129","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1016\/S2665-9913(24)00379-5","article-title":"Survival in patients with rheumatoid arthritis and recently diagnosed early-stage colorectal, lung, or prostate cancer receiving tumour necrosis factor inhibitors: a retrospective cohort study","volume":"7","author":"Ruiz","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"R40-20260129","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jbspin.2012.02.005","article-title":"Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis","volume":"80","author":"Dadoun","year":"2013","journal-title":"Joint Bone Spine"},{"key":"R41-20260129","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/acr.25053","article-title":"A narrowing mortality gap: temporal trends of cause-specific mortality in a national matched cohort study in US Veterans with rheumatoid arthritis","volume":"75","author":"Johnson","year":"2023","journal-title":"Arthritis Care Res"},{"key":"R42-20260129","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ard.2025.04.009","article-title":"Spatiotemporal distributions and regional disparities of rheumatoid arthritis in 953 global to local locations, 1980\u20132040, with deep learning-empowered forecasts and evaluation of interventional policies\u2019 benefits","volume":"84","author":"Jin","year":"2025","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:00:19Z","timestamp":1769666419000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000001142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000001142","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}